BACKGROUND: Frailty is an important clinical concern for the aging population of people living with HIV (PLWH). The objective of this study was to identify the combination of risk features that distinguish frail from nonfrail individuals. SETTING: Machine learning analysis of highly dimensional risk features was performed on a clinical cohort of PLWH. METHODS: Participants included 105 older (average age = 55.6) PLWH, with at least a 3-month history of combination antiretroviral therapy (median CD4 = 546). Predictors included demographics, HIV clinical markers, comorbid health conditions, cognition, and neuroimaging (ie, volumetrics, resting-state functional connectivity, and cerebral blood flow). Gradient-boosted multivariate regressions were implemented to establish linear and interactive classification models. Model performance was determined by sensitivity/specificity (F1 score) with 5-fold cross validation. RESULTS: The linear gradient-boosted multivariate regression classifier included lower current CD4 count, lower psychomotor performance, and multiple neuroimaging indices (volumes, network connectivity, and blood flow) in visual and motor brain systems (F1 score = 71%; precision = 84%; and sensitivity = 66%). The interactive model identified novel synergies between neuroimaging features, female sex, symptoms of depression, and current CD4 count. CONCLUSIONS: Data-driven algorithms built from highly dimensional clinical and brain imaging features implicate disruption to the visuomotor system in older PLWH designated as frail individuals. Interactions between lower CD4 count, female sex, depressive symptoms, and neuroimaging features suggest potentiation of risk mechanisms. Longitudinal data-driven studies are needed to guide clinical strategies capable of preventing the development of frailty as PLWH reach advanced age.
BACKGROUND: Frailty is an important clinical concern for the aging population of people living with HIV (PLWH). The objective of this study was to identify the combination of risk features that distinguish frail from nonfrail individuals. SETTING: Machine learning analysis of highly dimensional risk features was performed on a clinical cohort of PLWH. METHODS:Participants included 105 older (average age = 55.6) PLWH, with at least a 3-month history of combination antiretroviral therapy (median CD4 = 546). Predictors included demographics, HIV clinical markers, comorbid health conditions, cognition, and neuroimaging (ie, volumetrics, resting-state functional connectivity, and cerebral blood flow). Gradient-boosted multivariate regressions were implemented to establish linear and interactive classification models. Model performance was determined by sensitivity/specificity (F1 score) with 5-fold cross validation. RESULTS: The linear gradient-boosted multivariate regression classifier included lower current CD4 count, lower psychomotor performance, and multiple neuroimaging indices (volumes, network connectivity, and blood flow) in visual and motor brain systems (F1 score = 71%; precision = 84%; and sensitivity = 66%). The interactive model identified novel synergies between neuroimaging features, female sex, symptoms of depression, and current CD4 count. CONCLUSIONS: Data-driven algorithms built from highly dimensional clinical and brain imaging features implicate disruption to the visuomotor system in older PLWH designated as frail individuals. Interactions between lower CD4 count, female sex, depressive symptoms, and neuroimaging features suggest potentiation of risk mechanisms. Longitudinal data-driven studies are needed to guide clinical strategies capable of preventing the development of frailty as PLWH reach advanced age.
Authors: Serena Spudich; Kevin R Robertson; Ronald J Bosch; Rajesh T Gandhi; Joshua C Cyktor; Hanna Mar; Bernard J Macatangay; Christina M Lalama; Charles Rinaldo; Ann C Collier; Catherine Godfrey; Joseph J Eron; Deborah McMahon; Jana L Jacobs; Dianna Koontz; Evelyn Hogg; Alyssa Vecchio; John W Mellors Journal: J Clin Invest Date: 2019-07-15 Impact factor: 14.808
Authors: Marc A Norman; David J Moore; Michael Taylor; Donald Franklin; Lucette Cysique; Chris Ake; Deborah Lazarretto; Florin Vaida; Robert K Heaton Journal: J Clin Exp Neuropsychol Date: 2011-06-24 Impact factor: 2.475
Authors: Gary Marks; Lytt I Gardner; Charles E Rose; Anne Zinski; Richard D Moore; Susan Holman; Allan E Rodriguez; Meg Sullivan; Thomas P Giordano Journal: AIDS Date: 2015-05-15 Impact factor: 4.177
Authors: Kristine M Erlandson; Jennifer A Schrack; Catherine M Jankowski; Todd T Brown; Thomas B Campbell Journal: Curr HIV/AIDS Rep Date: 2014-09 Impact factor: 5.071
Authors: Patrick Luckett; Robert H Paul; Jaimie Navid; Sarah A Cooley; Julie K Wisch; Anna H Boerwinkle; Dimitre Tomov; Beau M Ances Journal: J Acquir Immune Defic Syndr Date: 2019-12-15 Impact factor: 3.731
Authors: Robert H Paul; Kyu Cho; Andrew Belden; Adam W Carrico; Eileen Martin; Jacob Bolzenius; Patrick Luckett; Sarah A Cooley; Julie Mannarino; Jodi M Gilman; Mariah Miano; Beau M Ances Journal: J Neuroimmune Pharmacol Date: 2022-01-04 Impact factor: 4.147
Authors: Jiequan Zhang; Qingyu Zhao; Ehsan Adeli; Adolf Pfefferbaum; Edith V Sullivan; Robert Paul; Victor Valcour; Kilian M Pohl Journal: Med Image Anal Date: 2021-10-13 Impact factor: 8.545
Authors: Collin B Kilgore; Jeremy F Strain; Brittany Nelson; Sarah A Cooley; Alexander Rosenow; Michelle Glans; William Todd Cade; Dominic N Reeds; Robert H Paul; Beau M Ances Journal: J Acquir Immune Defic Syndr Date: 2022-04-15 Impact factor: 3.771
Authors: Robert H Paul; Cecilia M Shikuma; Nguyen Van Vinh Chau; Lishomwa C Ndhlovu; Nguyen Tat Thanh; Andrew C Belden; Dominic C Chow; Glen M Chew; Thomas A Premeaux; Vo Trieu Ly; Joseph A D McBride; Jacob D Bolzenius; Thuy Le Journal: Front Neurol Date: 2021-03-12 Impact factor: 4.003
Authors: Lei Zhang; Jason J Ong; Xianglong Xu; Christopher K Fairley; Eric P F Chow; David Lee; Ei T Aung Journal: Sci Rep Date: 2022-05-24 Impact factor: 4.996